Vanda Pharmaceuticals | VNDA - Ebit


Vanda Pharmaceuticals reported $-10.28M in EBIT for its fiscal quarter ending in December of 2024.





Ebit Change Date
Acadia Pharmaceuticals USD 17.39M 18.36M Dec/2025
Agios Pharmaceuticals USD -121.58M 4.71M Dec/2025
Akebia Therapeutics USD -5.45M 9.4M Dec/2025
Alnylam Pharmaceuticals USD 29.4M 59.36M Dec/2025
Anika Therapeutics USD 646K 3.88M Dec/2025
Arrowhead Research USD 40.81M 17.01M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Enanta Pharmaceuticals USD -23.54M 6.31M Dec/2024
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Halozyme Therapeutics USD -88.41M 306.33M Dec/2025
Heron Therapeutics USD 38K 3.83M Dec/2025
Insmed USD -249.71M 11.64M Dec/2025
J&J USD 6.62B 1.51B Mar/2026
Lexicon Pharmaceuticals USD -14.78M 2.59M Dec/2025
Ligand Pharmaceuticals USD 158.89M 115.32M Sep/2025
Merck USD 6.24B 1.32B Dec/2025
Minerva Neurosciences USD -4.37M 1.71M Sep/2024
Moderna USD -857M 597M Dec/2025
Novartis USD 4.06B 413M Dec/2025
Pfizer USD 4.65B 71M Dec/2025
PTC Therapeutics USD -81.62M 85.11M Dec/2025
Puma Biotechnology USD -2.2M 11.41M Jun/2024
Sanofi EUR 1.7B 2.17B Dec/2025
Takeda JPY 257.49B 568.56B Dec/2025
Teva Pharmaceutical Industries USD 577M 491M Dec/2025
Ultragenyx Pharmaceutical USD -114M 56.89M Dec/2025
Vanda Pharmaceuticals USD -10.28M 721K Dec/2024
Veracyte USD 24.63M 1.52M Dec/2025